SynthesisBMJ (Clinical research ed.)2019

Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis.

Yi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.